Home > Psychogenics Salary

Psychogenics Salary

  • 43
  • 22
  • 18
Psychogenics average salary is $65,128, median salary is $81,120 with a salary range from $38,600 to $83,200.
Psychogenics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Psychogenics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 4 Psychogenics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Senior Civil Engineer 81,120-81,120 Hackensack, NJ, 07601 2017 Psychogenics Senior Civil Engineer Salaries (2)
Psychogenics Hackensack, NJ Salaries
Civil Engineer 81,120-81,120 Hackensack, NJ, 07601 2017 Psychogenics Civil Engineer Salaries (1)
Psychogenics Hackensack, NJ Salaries
Architectural Drafter 38,600-41,600 Hackensack, NJ, 07601 2016 Psychogenics Architectural Drafter Salaries (2)
Psychogenics Hackensack, NJ Salaries
Senior Civil Engineer 83,200-83,200 Hackensack, NJ, 07601 2016 Psychogenics Senior Civil Engineer Salaries (2)
Psychogenics Hackensack, NJ Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Psychogenics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Psychogenics Jobs
See more Psychogenics Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Psychogenics... Information
  • PsychoGenics Inc
  • Industry: BioTech/Drugs
  • City: Tarrytown, NY
  • PsychoGenics, a private biopharmaceutical company, with expertise in thefield of behavioral neurobiology, and provider CNS drug discovery solutions toPharmaceutical and Biotechnology companies, is combining its expertise inbehavior with the power of bioinformatics to develop a breakthrough, in vivopreclinical behavioral testing platform. This automated and computerizedhigh-throughput platform offers companies an alternative approach to targetdiscovery and validation, and drug discovery by providing faster, moreobjective and higher quality results than traditional, subjective manualapproaches.